Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

How to read a next-generation sequencing report-what oncologists need to know

Autor: S. Schmid, W. Jochum, B. Padberg, I. Demmer, K.D. Mertz, M. Joerger, C. Britschgi, M.S. Matter, S.I. Rothschild, A. Omlin

Publikováno v: Schmid, S; Jochum, W; Padberg, B; Demmer, I; Mertz, K D; Joerger, M; Britschgi, C; Matter, M S; Rothschild, S I; Omlin, A (2022). How to read a next-generation sequencing report-what oncologists need to know. ESMO open, 7(5), p. 100570. BMJ 10.1016/j.esmoop.2022.100570

Next-generation sequencing (NGS) of tumor cell-derived DNA/RNA to screen for targetable genomic alterations is now widely available and has become part of routine practice in oncology. NGS testing strategies depend on cancer type, disease stage and t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c60725c1555020b1d3d68624ca5787

431P Neoadjuvant treatment with regorafenib and capecitabine combined with radiotherapy in locally advanced rectal cancer: A multicenter phase Ib trial (RECAP) SAKK 41/16

Autor: S. Bastian, M. Joerger, D. Baertschi, L. Holer, M. Guckenberger, W. Jochum, D. Koeberle, A.R. Siebenhüner, M.D. Berger, R.C. Winterhalder, C.R. Largiadèr, M. Löffler-Baumann, K. Mosna- Firlejczyk, A. Wicki, A. Fischer Maranta, R.A.F. von Moos

Publikováno v: Annals of Oncology. 33:S731-S732

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fd2517684d44bd6211451b408d529e9f
https://doi.org/10.1016/j.annonc.2022.07.569

200MO Anti–IL-8 BMS-986253 + nivolumab (NIVO) ± ipilimumab (IPI) in patients (pts) with advanced cancer: Update of initial phase I results

Autor: M. Simonelli, E. Calvo, D. Davar, D. Richards, M. Gutierrez, V. Moreno Garcia, T. Marron, S. Rottey, A. Orcurto, D.J. Renouf, M. Joerger, S. Barriga Falcon, J. Fan, E. Gibson, D. Chakraborty, V. Arora, I. Melero

Publikováno v: Immuno-Oncology and Technology. 16:100311

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::95e40f094659e0a29a5effab053ed051
https://doi.org/10.1016/j.iotech.2022.100311